Lakefront Biotherapeutics (LKFT) EBT Growth (3y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 47.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.76% |
| Dec 31, 2025 | 143.14% |
| Sep 30, 2025 | -134.24% |
| Jun 30, 2025 | 59.44% |
| Mar 31, 2025 | -138.09% |
| Dec 31, 2024 | 66.38% |
| Sep 30, 2024 | 19.03% |
| Jun 30, 2024 | 39.97% |
| Mar 31, 2024 | 56.18% |
| Dec 31, 2023 | 37.91% |
| Sep 30, 2023 | 56.07% |
| Jun 30, 2023 | 51.26% |
| Mar 31, 2023 | 39.05% |
| Dec 31, 2022 | 14.17% |
| Sep 30, 2022 | -28.24% |
| Jun 30, 2022 | -17.40% |
| Mar 31, 2022 | 37.99% |
| Dec 31, 2021 | -32.00% |
| Sep 30, 2021 | -126.67% |
| Jun 30, 2021 | -33.15% |